The price of Depomed, Inc. (NASDAQ:DEPO) over the past year has decreased -59.41% while the S&P 500 has increased 18.74%. During the past 20 days, DEPO has increased 77.85% while the broad market has increased 1.77%. DEPO ‘s 20-day moving average currently sits above its 100-day moving average. This is a bullish signal that suggests the stock price might continue to rise. DEPO’s average trading volume during the past 20 days is lower than the average volume over the past 100 days, which could be an indication that investors are feeling less certain than usual about the direction of DEPO’s future price movements.
Recent trading patterns in the stock of Depomed, Inc. (DEPO) have investors on high alert. Analysts often look at historical trading patterns to predict a stock’s future performance. In the case of DEPO, the data might be telling investors a thing or two about where the stock is headed. In the most recent quarter, institutional ownership decreased by a net of 35807 shares, or 0.06%.This is a bearish sign and indicates that institutions are feeling more pessimistic about the outlook for DEPO overall.89 holders increased their positions, 75 decreased their positions, and 33 holders held their positions.
Among institutions that increased their positions, 19 were new positions. Among holders that decreased their positions, 28 sold out of the stock Depomed, Inc.. Insider ownership during the latest quarter decreased by a net of 11048 shares, indicating that DEPO’s key executives are feeling more bearish about the stock than they did three months ago. 1 or 33.33% of the trades during the past quarter were buys, and 2 or 66.67% were sells. This activity represents a continuation of a theme over the past twelve months. Insider ownership during the last year has decreased by a net of 311407 shares. 23.08% of insider trades in the last 12 months were buys, and 76.92% were sells.
Depomed, Inc. (NASDAQ:DEPO) has a 20-day RSI of 73.89%. According to this momentum indicator, a reading above 70 suggests the stock is entering overbought territory and that the recent uptrend may be about to reverse. The MACD tells a similair story. DEPO’s 9-day MACD currently sits below the 20-day MACD, indicating that DEPO’s upside momentum has decreased during the last three weeks. This suggests that the trend might soon reverse. DEPO’s average trading volatility during the past few weeks is -10.14% lower than the average volatility over the past 100 days. This means that the stock’s daily price swings have been less extreme in recent times compared to the past.
Analysts expect Depomed, Inc. (DEPO) to generate earnings per share of $1.34 in 2017. This works out to a decrease of -7.59% compared to last year’s earnings. For comparison’s sake, analysts expect the S&P 500 to grow earnings by an average of 12% in 2017. The average investment rating for DEPO on a scale of 1 to 5 (1 being a strong sell and 5 being a strong buy) is a 3.29 or a Hold. Three months ago, analysts assigned DEPO a 3.33 rating, which implies that analysts have become more pessimistic about the outlook for the stock over the next year.